Results 161 to 170 of about 8,379,611 (261)
Voice Quality in Individuals With Acquired Immunodeficiency Syndrome
ABSTRACT Background Speech and voice disorders are frequently observed in individuals with acquired immunodeficiency syndrome (AIDS). However, the literature lacks detailed descriptions of how perceptual and acoustic characteristics manifest in the voice quality profiles of this population.
Vanessa Medina +4 more
wiley +1 more source
Financing issues in proposed HIV/AIDS intervention of providing anti-retroviral drugs to selected regions in India [PDF]
The development of antiretroviral therapy has given a new hope for people living with acquired immuno deficiency syndrome. In the face of increased disease burden due to HIV the global and political commitment towards controlling the pandemic has ...
Bhat Ramesh, Saha Somen
core
Among 4574 adults with HIV in Kaiser Permanente Northern California, latent class analysis identified four syndemic classes combining alcohol use with co‐occurring conditions: Heavy Use/Complex Behavioral Multimorbidity, Moderate Use/High Cardiometabolic Burden, Low Use/High Medical Morbidity, and Moderate Use/Low Morbidity.
Natalia Van Doren +16 more
wiley +1 more source
Echocardiographic Assessment of Systolic Pulmonary Arterial Pressure in HIV-Positive Patients
Pulmonary hypertension is rare but is one of the complications that occur due to HIV infection. Symptoms of HIV-associated pulmonary arterial hypertension are often non-specific but the main symptom of the disease is dyspnea.
Mehrnaz Rasoulinejad +8 more
doaj
Adherence to and effectiveness of Highly Active Antiretroviral Treatment for HIV infection: assessing the bidirectional relationship [PDF]
It is well-established that high adherence to HAART is a major determinant of virological and immunological success. Furthermore, psycho-social research has identified a wide range of adherence factors.
François Raffi +9 more
core
People living with HIV (PWH) face an increased risk of Type 2 diabetes mellitus (T2DM) and cardiovascular events (CVEs), highlighting the need for simple risk stratification tools. In this retrospective study of 477 PWH followed for 14.2 years, a higher triglyceride‐glucose (TyG) index independently predicted incident T2DM and CVEs.
Daniele Pastori +6 more
wiley +1 more source
Cytopenias With HIV in the Era of Highly Active Antiretroviral Therapy: Are We Winning the Battle? [PDF]
Obeagu EI.
europepmc +1 more source
Abstract Objectives Increasing rates of HIV‐1 drug resistance (HIVDR) threaten the effectiveness of antiretroviral therapy (ART) programmes in sub‐Saharan Africa, particularly among children, adolescents and young adults, who face limited treatment options.
Dominic Rauschning +16 more
wiley +1 more source
Beyond CD4: Posterior segment findings and virologic-immunologic predictors in highly active antiretroviral therapy-naïve HIV patients. [PDF]
Hayat SC +4 more
europepmc +1 more source
Abstract Objectives Cardiovascular disease (CVD) is a major comorbidity and leading cause of morbidity and mortality in people with HIV (PWH). The REPRIEVE trial demonstrated that statin therapy significantly reduces cardiovascular events in PWH, prompting updated recommendations from major international societies.
Jasmini Alagaratnam +3 more
wiley +1 more source

